Centene, Magellan Satisfy All Regulatory Approvals For Completion Of Acquisition Agreement

Centene Corporation (NYSE:CNC) and Magellan Health, Inc. (NASDAQ:MGLN) today announced that they have obtained all required regulatory approvals necessary to close Centene's pending acquisition of Magellan Health. Subject to the satisfaction of customary closing deliveries, the parties anticipate closing the acquisition on or about January 4, 2022.

The agreement enables Centene to provide whole-health solutions across physical and mental health to deliver better health outcomes at lower costs for complex, high-cost populations.

"We are pleased to achieve this regulatory milestone, and we look forward to a timely close of the transaction. Our combined company will have expanded reach in a variety of specialty services and will provide increased access to behavioral health care during a time of need for the communities we serve," said Michael Neidorff, Chairman and Chief Executive Officer of Centene.